| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing salicylic acid and white petrolatum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only Podophyllum resin and salicylic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Camphor and salicylic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Benzoic acid and salicylic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Betamethasone and salicylic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Coal tar and dithranol and salicylic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Coal tar and salicylic acid and sulfur only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Desoximetasone and salicylic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only dithranol and salicylic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Heparinoid and salicylic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only lactic acid and salicylic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salicylic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only salicylic acid and sulfur (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only salicylic acid and white petrolatum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salicylic acid and zinc oxide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only rhubarb and salicylic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Heparinoid and salicylic acid only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Heparinoid and salicylic acid only product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only lactic acid and salicylic acid in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only benzoic acid and salicylic acid in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Betamethasone and salicylic acid only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only coal tar and dithranol and salicylic acid in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salicylic acid and white soft paraffin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only salicylic acid in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dithranol and salicylic acid only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only Podophyllum resin and salicylic acid in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salicylic acid 110 mg/g cutaneous gel |
Has basis of strength substance (attribute) |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salicylic acid 110 mg/g cutaneous gel |
Has precise active ingredient |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salicylic acid 60 mg/g cutaneous gel |
Has precise active ingredient |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salicylic acid 60 mg/g cutaneous gel |
Has basis of strength substance (attribute) |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lactic acid 250 mg/g and salicylic acid 250 mg/g cutaneous ointment |
Has basis of strength substance (attribute) |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lactic acid 250 mg/g and salicylic acid 250 mg/g cutaneous ointment |
Has precise active ingredient |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely salicylic acid 50 microgram/1 milligram and zinc oxide 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) |
Has precise active ingredient |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely salicylic acid 50 microgram/1 milligram and zinc oxide 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) |
Has basis of strength substance (attribute) |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salicylic acid 170 mg/mL cutaneous solution |
Has basis of strength substance (attribute) |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salicylic acid 170 mg/mL cutaneous solution |
Has precise active ingredient |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lactic acid (as ammonium lactate) 167 mg/mL and salicylic acid 167 mg/mL cutaneous solution |
Has precise active ingredient |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lactic acid (as ammonium lactate) 167 mg/mL and salicylic acid 167 mg/mL cutaneous solution |
Has basis of strength substance (attribute) |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing ammonium lactate and salicylic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salicylic acid- and zinc oxide-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salicylic acid and zinc oxide only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only anthraquinone glycoside and salicylic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only salicylic acid and sulfur in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely salicylic acid 30 milligram/1 milliliter and sulfur 50 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
Has precise active ingredient |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely salicylic acid 30 milligram/1 milliliter and sulfur 50 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
Has basis of strength substance (attribute) |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Anthraquinone glycoside- and salicylic acid-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ammonium lactate and salicylic acid only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Boric acid- and salicylic acid-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Boric acid and salicylic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Boric acid- and salicylic acid-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only boric acid and salicylic acid in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing anthraquinone glycoside and salicylic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salicylic acid- and sulfur-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
Has precise active ingredient |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
Has basis of strength substance (attribute) |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ammonium lactate- and salicylic acid-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ammonium lactate and salicylic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Coal tar 10 mg/g and dithranol 1.1 mg/g and salicylic acid 16 mg/g cutaneous ointment |
Has basis of strength substance (attribute) |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Coal tar 10 mg/g and dithranol 1.1 mg/g and salicylic acid 16 mg/g cutaneous ointment |
Has precise active ingredient |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Podophyllin+salicylic acid 20/25% ointment (substance) |
Has basis of strength substance (attribute) |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Podophyllin+salicylic acid 20/25% ointment (substance) |
Has precise active ingredient |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Has precise active ingredient |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Has basis of strength substance (attribute) |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Has precise active ingredient |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Has basis of strength substance (attribute) |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
Has precise active ingredient |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
Has basis of strength substance (attribute) |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely dithranol 2.5 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has precise active ingredient |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely dithranol 2.5 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has basis of strength substance (attribute) |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely salicylic acid 600 milligram/1 gram and white petrolatum 400 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has basis of strength substance (attribute) |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely salicylic acid 600 milligram/1 gram and white petrolatum 400 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has precise active ingredient |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Coal tar- and salicylic acid-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Coal tar and salicylic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Coal tar- and salicylic acid-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Coal tar and salicylic acid only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely coal tar 60 milligram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has precise active ingredient |
False |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely coal tar 60 milligram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
False |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely salicylic acid 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has precise active ingredient |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely salicylic acid 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Betamethasone (as betamethasone dipropionate) 500 microgram/mL and salicylic acid 30 mg/mL cutaneous lotion |
Has precise active ingredient |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Betamethasone (as betamethasone dipropionate) 500 microgram/mL and salicylic acid 30 mg/mL cutaneous lotion |
Has basis of strength substance (attribute) |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Coal tar 60 mg/g and salicylic acid 30 mg/g cutaneous ointment |
Has precise active ingredient |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Coal tar 60 mg/g and salicylic acid 30 mg/g cutaneous ointment |
Has basis of strength substance (attribute) |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely fluorouracil 5 milligram/1 gram and salicylic acid 100 milligram/1 gram conventional release cutaneous solution (clinical drug) |
Has precise active ingredient |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely fluorouracil 5 milligram/1 gram and salicylic acid 100 milligram/1 gram conventional release cutaneous solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Fluorouracil and salicylic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only fluorouracil and salicylic acid in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing fluorouracil and salicylic acid in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Fluorouracil- and salicylic acid-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salicylic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]